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Abstract  The  goal  of  the  present  study  is  to  describe  the  implementation  of  two  Evidence-
based treatments  (EBT)  for  adolescent  Cannabis  Use  Disorders  (CUD)  in  the  Spanish  Public
Health System,  and  its  main  clinical  outcomes.  Adolescent  Community  Reinforcement  Approach
(A-CRA) and  Contingency  Management  (CM)  were  chosen  as  the  most  efﬁcacious  treatment  pro-
grams for  this  population.  A  total  of  26  adolescent  cannabis  users  entered  the  study  (91.7%  male;
age =  16.50)  at  two  outpatient  clinical  facilities  in  Spain.  A  quasi-experimental  design  was  uti-
lized, with  one  group  receiving  A-CRA  only  and  the  other  A-CRA  +  CM.  Implementation  of  both
EBTs resulted  feasible,  with  positive  clinical  outcomes.  Results  indicated  that  A-CRA  has  posi-
tive retention  (81.3%)  and  abstinence  rates  (68.8%).  Results  for  the  group  receiving  A-CRA  +  CM
were not  signiﬁcantly  better  than  A-CRA  in  retention  (100%)  or  abstinence  (75.5%),  although
sample  is  too  small  to  establish  ﬁrm  conclusions.  Cannabis-related  problems  and  depressive
symptomatology  also  decreased  during  treatment.  Several  limitations  prevent  us  from  deter-
mining the  clinical  efﬁcacy  of  A-CRA  in  this  study.  The  process  of  translating  EBT’s  to  clinical
contexts  presented  with  many  difﬁculties  that  need  to  be  overcome.  Recommendations  are
made for  further  attempts  to  implement  EBTs  in  these  contexts.
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rights reserved.
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Tratamientos  basados  en  la  evidencia  para  adolescentes  con  trastornos  por  consumo
de  cannabis  en  el  Sistema  Público  de  Salud
Resumen  El  objetivo  de  este  estudio  era  describir  la  implementación  en  el  Sistema  Público
de Salud  de  dos  programas  basados  en  la  evidencia  (PBE)  para  adolescentes  con  trastornos  por
consumo de  cannabis,  y  sus  principales  resultados.  La  Aproximación  de  Reforzamiento  Comu-
nitario para  Adolescentes  (A-CRA)  y  el  Control  de  Contingencias  (MC)  fueron  elegidos  como
los programas  de  intervención  más  eﬁcaces  para  esta  población.  Un  total  de  26  adolescentes
participaron  en  el  estudio  (91.7%  chicos;  edad  media  =  16.50  an˜os)  en  dos  centros  de  carácter
ambulatorio  en  Espan˜a.  Se  utilizó  un  disen˜o  cuasi-experimental,  donde  un  grupo  recibió  A-CRA
y el  otro  A-CRA  +  MC.  La  implementación  de  ambos  programas  resultó  factible,  con  resultados
clínicos positivos.  El  A-CRA  ofreció  buenas  tasas  de  retención  (81.3%)  y  abstinencia  (68.6%).
Los resultados  del  grupo  A-CRA  +  MC  no  fueron  signiﬁcativamente  mejores  que  los  del  A-CRA  en
retención (100%)  o  abstinencia  (75.5%),  aunque  el  limitado  taman˜o  muestral  no  permite  estable-
cer conclusiones  ﬁrmes.  Los  problemas  asociados  al  cannabis  y  la  sintomatología  depresiva  se
redujeron durante  el  tratamiento.  Varias  limitaciones  nos  impiden  determinar  la  eﬁcacia  clínica
del A-CRA  en  este  estudio.  El  proceso  de  traslación  de  los  PBE  al  contexto  clínico  presentó  múlti-
ples diﬁcultades  que  deben  ser  abordadas.  Se  discuten  recomendaciones  para  futuros  intentos
de implementación  de  PBE  en  estos  contextos.
© 2014  Asociación  Espan˜ola  de  Psicología  Conductual.  Publicado  por  Elsevier  España,  S.L.  Todos
los derechos  reservados.
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inclusion  criteria.  All  adolescents  and  their  families  meet-In  Spain,  92%  of  adolescents  in  treatment  under  15  years
of  age  and  79%  of  those  aged  15-19  report  cannabis  as  their
primary  drug  of  abuse  (European  Monitoring  Centre  for  Drugs
and  Drug  Addiction,  2012).  However,  a  review  of  the  liter-
ature  shows  that  no  evidence-based  treatment  (EBT)  aimed
at  this  population  has  been  implemented  in  our  country.  The
need  for  such  treatment  programs  for  adolescent  Cannabis
Use  Disorders  (CUD)  in  Spain  is  very  urgent.  In  the  past
years,  several  controlled  studies  have  focused  on  treatment
for  CUD  for  adolescents  (Dennis  et  al.,  2004;  Hendriks,  van
der  Schee,  &  Blanken  2011;  Martin  &  Copeland,  2005;  Rigter
et  al.,  2013;  Walker  et  al.,  2011).  Among  these,  the  Cannabis
Youth  Treatment  study  (CYT)  is  the  largest  published  clinical
trial  (Dennis  et  al.,  2004).  Results  indicated  that  Adoles-
cent  Community  Reinforcement  Approach  (A-CRA)  was  the
most  cost-effective  intervention,  and  it  showed  a  non-
signiﬁcant  trend  for  higher  rates  of  recovery  one  year
after  treatment,  when  compared  to  MET/CBT5  (Motiva-
tional  Enhancement  Therapy/Cognitive  Behavioral  Therapy)
and  MDFT  (Multidimensional  Family  Therapy).  Despite  the
general  effectiveness,  however,  the  most  powerful  interven-
tions  tested  so  far  with  adolescent  cannabis  users  achieved
only  modest  abstinence  rates  and  substance  use  reductions
(Stanger  &  Budney,  2010).  In  this  context,  the  integra-
tion  of  abstinence-based  contingency  management  (CM)  is
a  promising  approach  (Nordstrom  &  Levin,  2007;  Stanger  &
Budney,  2010)  that  has  proved  to  be  an  efﬁcacious  model
for  adolescent  marijuana  abuse  (Kamon,  Budney,  &  Stanger
2005;  Stanger,  Budney,  Kamon,  &  Thostensen,  2009).
The  goal  of  the  present  study  was  to  describe  a  pilot
implementation  of  two  EBTs  for  adolescent  CUDs  in  the
Spanish  Public  Health  System.  A-CRA  was  chosen  given  its
positive  implementation  rates  and  effectiveness  (Godley,
Garner,  Smith,  Meyers,  &  Godley,  2011),  as  well  as  its  ﬂex-
ibility  to  address  clients’  individual  needs  (Godley,  White,
Diamond,  Passetti,  &  Titus,  2001).  A-CRA  was  then  partially
i
p
mombined  with  an  abstinence-based  CM  program  using  a
uasi-experimental  design,  given  its  demonstrated  efﬁcacy
ith  adolescents  (Stanger  &  Budney,  2010).We  aimed  to
ssess  the  clinical  outcomes,  determine  the  feasibility
nd  limitations  of  the  therapeutic  approaches  and  their
ntegration,  and  to  discuss  the  barriers  encountered  in  this
peciﬁc  context.
ethod
articipants
articipants  were  recruited  from  those  requesting  treat-
ent  in  clinical  settings  and  through  advertisements  in
amphlets,  on  radio  and  in  local  newspapers.  Any  demand
f  treatment  from  an  adolescent  or  their  families  related  to
rug  use  problems  was  considered  for  inclusion  in  the  study.
nclusion  criteria  for  individuals  to  participate  were:  (1)
eing  aged  12-18,  (2)  Individual  or  family  report  of  cannabis
se  in  the  previous  30  days  or  delivering  a  positive  urinal-
sis  at  intake,  and  (3)  Living  with  a  responsible  adult  who
greed  to  participate.  Exclusion  criteria  included  (1)  Pre-
enting  a  mental  or  physical  disorder  requiring  more  speciﬁc
reatment,  (2)  Having  a  substance-use  disorder  requiring
ore  intense  or  inpatient  treatment,  (3)  Not  living  within
0  minutes  of  the  treatment  facility,  and  (4)  Not  being  ﬂu-
nt  in  Spanish.  All  participants  and  their  families  provided
nformed  consent.
In  the  Principality  of  Asturias,  70  participants  requested
reatment  and  19  (27.1%)  met  the  inclusion  criteria.  In
adrid,  63  requested  treatment  and  7  (11.1%)  met  theng  inclusion  criteria  agreed  to  participate.  A  total  of  26
articipants  (19.55%)  were  allocated  to  one  of  the  two  treat-
ent  conditions.  Two  adolescents  abandoned  the  study  after
188  S.  Fernández-Artamendi  et  al.
Eligible for assessment
(N = 133)
Excluded (N = 107)
- Other mental health issues (N = 47)
- No family support (N = 22)
- Other primary drug (N = 8)
- Refused to participate (N = 2)
- Therapist overload (N = 1)
- Justice system (N = 33)AllocatedN = 26
A-CRA
(N = 16)
A-CRA+CM
(N = 10)
Received intervention
(N = 8)
Excluded
           (N = 2) 
- Lost before treatment
initiation
Received intervention
(N = 16)
Discharge (N = 8)
- Incomplete discharge
  evaluation (N = 1)
Discharge (N = 13)
Early dropout (N = 3)
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eFigure  1  Flow  Diagram  of
llocation  and  before  completing  intake  assessment  (see
igure  1).
rocedure
 quasi-experimental  design  with  two  treatment  conditions
as  implemented.  Participants  were  randomized  between
reatment  conditions  (A-CRA  and  A-CRA  plus  CM)  unless
therwise  considered  by  clinical  judgment.  Treatment  goal
egarding  substance  use  was  abstinence  from  cannabis
nd  other  illegal  drugs  in  both  groups.  Participants  who
equested  treatment  for  their  CUD  at  the  Asturias  and
adrid  outpatient  facilities  entered  the  study  if  meeting
he  criteria  described  above.  Both  clinical  settings  delivered
-CRA  and  A-CRA  +  CM.  Before  treatment  entry,  partici-
ants  and  responsible  adults  provided  informed  consent  to
nter  the  study.  The  Ethics  Committee  of  the  University  of
viedo  approved  this  research  study.  All  participants  were
valuated  at  intake  and  post-treatment  (3  months  later).
rinalyses  were  carried  out  weekly  during  the  ﬁrst  two
eeks  devoted  to  intake  assessment  and  before  treatment
ntry,  and  twice  weekly  during  treatment.
This  study  was  carried  out  simultaneously  in  two  settings
ithin  the  Spanish  Public  Health  System.  In  Asturias,  they
ere  implemented  in  an  outpatient  setting  delivering  treat-
ent  for  adolescents  (ProgramaReciella,  CESPA-Proyecto
ombre  Asturias).  In  Madrid,  at  the  Center  for  Drug  Addic-
ion  belonging  to  MadridSalud.Adolescent  Community  Reinforcement  Approach  (A-
RA).  Translation  of  the  A-CRA  manual  was  carried  out  by
xperts  in  English  and  Spanish,  who  translated  it  into  Spanish
nd  then  back-translated  from  Spanish  to  English.  The  A-CRA
u
0
t
6icipants  entering  the  study.
s  an  adaptation  of  the  Community  Reinforcement  Approach
CRA)  that  was  initially  developed  and  tested  with  adults
Godley,  Meyers,  et  al.,  2001).  The  program  is  composed
f  10  individual  sessions  with  the  adolescent  and  four  fam-
ly  sessions,  which  include  2  sessions  for  caregivers  alone
nd  2  sessions  for  the  adolescent  and  caregivers  together.
-CRA  is  aimed  at  increasing  adolescents’  access  to  social
einforcers  in  the  community  through  skills-training  and
ngagement  procedures.  A-CRA  clinicians  use  a  positive  non-
onfrontational  approach  to  promote  abstinence,  establish
ositive  peer  relationships  and  improve  family  relationships.
he  nineteen  speciﬁc  A-CRA  procedures  can  be  used  repeat-
dly  in  sessions  in  a  ﬂexible  manner,  based  on  clinical  needs.
essions  last  an  average  of  1  hour.  The  therapeutic  work  in
-CRA  extended  over  a  period  of  12  to  14  weeks.
Contingency  Management.  Only  participants  in  the  A-
RA  +  CM  condition  received  vouchers,  following  a  schedule
reated  based  on  previous  studies  (Stanger  et  al.,  2009).
ince  many  regular  cannabis  users  need  at  least  two  weeks
o  test  negative  after  starting  abstinence  at  cut-off  level
f  50  ng/ml  (Goodwin  et  al.,  2008),  the  ﬁrst  two  weeks  of
re-treatment  were  considered  a washout  period.  To  facil-
tate  compliance  in  providing  specimens,  during  the  ﬁrst
wo  weeks  of  pre-treatment  participants  received  vouchers
orth  4D  for  each  weekly  urine  specimen  irrespective  of  its
esults.  During  12  consecutive  weeks  during  treatment,  par-
icipants  earned  vouchers  contingent  on  negative  results.
he  CM  schedule  assigned  an  increasing  voucher  value  for
ach  consecutive  negative  specimen  to  reinforce  contin-
ous  abstinence.  The  schedule  began  with  a  3D  voucher,
.50D  being  added  to  each  consecutive  negative  result,  up
o  the  maximum  value  of  14.5D .  A  bonus  voucher  worth
D  was  earned  by  participants  for  each  continuous  week  of
e  di
r
b
S
d
h
F
T
o
a
2
s
i
r
i
m
w
a
s
t
D
T
d
(
s
w
p
u
t
c
r
p
i
p
f
A
p
M
r
c
w
(
(
c
3
s
o
w
p
t
iEvidence-based  treatments  for  adolescents  with  cannabis  us
abstinence.  A  positive  result  or  failure  to  provide  a  valid
sample  implied  a  positive  urinalysis  and  the  schedule  being
reset  to  the  start  (3D  ).  Participants  could  move  up  again
through  the  schedule,  but  catching  up  with  their  previously-
achieved  maximum  value  after  providing  two  consecutive
negative  urine  specimens.  Maximum  value  of  vouchers  they
could  earn  was  290D ,  which  could  be  exchanged  for  leisure
and  sports  activities.
Staff  Training.  The  staff  was  made  up  of  5  therapists.
All  were  Licensed  Clinical  Psychologists  with  expertise  in
the  ﬁeld  of  adolescent  drug-use  treatment.  All  of  them
received  15  hours  of  training  in  the  basics  of  A-CRA/CM  pro-
gram,  its  procedures  and  the  assessment  instruments  by  a
Licensed  Clinical  Psychologist  and  Researcher  with  expertise
in  Community  Reinforcement  Approach.  Their  participation
was  integrated  with  the  delivery  of  regular  services  to  other
young  and  adult  patients  ineligible  for  this  study.  Therapists
were  randomized  between  treatment  conditions.
Instruments
Urinalysis
Adolescents  provided  two  weekly  urine  specimens  during  a
pre-treatment  period  devoted  to  intake  assessment.  During
the  treatment  period  participants  provided  one  sample  on
the  day  of  the  therapeutic  session  and  a  second  one  in  an
additional  visit  to  the  center.  Results  were  available  for  the
adolescent  and  his/her  responsible  adult  within  10  minutes.
Urinalyses  (UA)  were  carried  out  using  Instant  Urine  Drug
Testing  Kits  by  Perfelena®  to  detect  the  presence  of  several
cannabis  metabolites,  with  cutoff  levels  of  50  ng/ml.
Substance use Severity
The  presence  of  Cannabis  Abuse  in  the  previous  12  months
was  assessed  by  the  therapist  following  DSM-IV-TR  crite-
ria.  The  Teen-Addiction  Severity  Index  (T-ASI)  (Kaminer,
Burkstein,  &  Tarter,  1991)  was  utilized  to  collect  information
on  patterns  of  drug  use  at  intake:  age  of  onset  of  cannabis
use,  months  using  cannabis,  days  of  alcohol  and  cannabis
use  (in  the  last  30),  report  of  legal  issues  and  illicit  drug
use.  This  instrument  has  shown  high  inter-rater  agreement,
with  an  average  correlation  across  scales  of  .78.  The  Spanish
version  (Fernandez-Artamendi  et  al.,  2012)  of  the  Cannabis
Problems  Questionnaire  for  Adolescents  (CPQ-A)  was  used
to  assess  the  severity  of  cannabis-related  problems.  The
CPQ-A  consists  of  27  items  with  a  dichotomous  response  for-
mat,  and  has  shown  high  reliability  with  Spanish  adolescents
(Cronbach’s  alpha  =  .86).
Psychopathology
The  Child  Behavior  Checklist  (CBCL)  (Achenbach,  1991) is  a
self-report  instrument  for  detecting  emotional  and  behav-
ioral  problems  in  the  past  six  months  for  children  and
adolescents  aged  6  to  18.  It  consists  of  113  questions,  scored
on  a  three-point  Likert  scale,  and  provides  scores  on  three
global  scales:  internalizing  and  externalizing  symptoms,  and
global  symptomatology.  Internal  consistency  of  subscales
9
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anges  between  .78  and  .97,  and  inter-rater  reliability  is
etween  .93  and  .96.  Beck  Depression  Inventory-II  (Beck,
teer,  Ball,  &  Ranieri,  1996).  A  comprehensive  screening  of
epressive  symptoms  with  21  items  rated  from  0  to  3,  with
igh  reliability  (Cronbach’s  alpha  =  .91)
eedback from therapists
o  assess  the  opinion  of  the  therapists  on  the  experience
f  implementing  A-CRA  and  CM,  two  short  scales  were  cre-
ted  based  on  previous  literature  (Nelson,  Steele,  &  Mize,
006).  One  scale  assessed  the  opinion  of  therapists  exclu-
ively  on  A-CRA  and  the  other  on  CM  only.  Each  scale
ncluded  nine  questions,  with  Likert-type  response  options
anging  from  1  (very  low/bad)  to  5  (very  high/good). Qual-
tative  data  was  collected  on  the  therapist’s  impressions  by
eans  of  a  telephone  interview  in  which  the  following  topics
ere  discussed:  ‘Treatment  adequacy  for  the  population
ttended’,  ‘Integration  of  treatment  programs  in  regular
ervice’,  ‘Positive  and  negative  aspects  of  the  implemen-
ation’  and  ‘Limitations  of  the  intervention’.
ata analyses
he  ﬂow  of  participants  from  ﬁrst  request  to  discharge  is
escribed  by  means  of  a  ﬂow  chart  to  facilitate  reading
Hartley,  2012),  detailing  the  prevalence  of  each  inclu-
ion/exclusion  criterion  (see  Figure  1).  Descriptive  statistics
ere  utilized  to  report  baseline  characteristics  of  partici-
ants.  Statistical  differences  between  groups  were  sought
sing  Fisher  Exact  Test  to  compare  frequencies,  and  in  order
o  prevent  Family-wise  errors,  ANOVA  was  used  to  conduct
omparisons  between  means.  Details  on  implementation  are
eported  with  descriptive  statistics.
Dependent  t-test  statistics  and  Fisher  Exact  Tests  were
erformed  to  assess  changes  in  psychopathology  between
ntake  and  end  of  treatment.  Participants  who  did  not
rovide  intake  and  discharge  assessments  were  excluded
rom  these  analyses.
To  compare  substance  use  outcomes  between  groups,
NOVA  and  Fisher  Exact  Test  were  utilized,  selecting
articipants  based  on  an  intent-to-treat  model  (Austin,
acgowan,  &  Wagner,  2005).  Abstinence  was  analyzed  using
esults  from  UAs,  calculating:  longest  duration  of  continuous
annabis  abstinence  (two  consecutive  weekly  samples  =  1
eek),  point-prevalence  abstinence  at  months  1,  2  and  3
discharge),  percentage  of  negative  specimens  delivered
compared  to  all  due  samples)  and  percentage  of  adoles-
ents  ‘‘in-recovery’’  based  on  UAs  (abstinence  in  the  prior
0  days  at  the  end  of  treatment).  Missing  samples  were  con-
idered  positive  in  order  to  report  a  conservative  estimation
f  abstinence,  except  for  continuous  abstinence,  where  they
ere  interpolated  (considered  negative  only  if  they  were
receded  and  followed  by  a  negative  UA;  otherwise  posi-
ive).  Only  9%  of  due  samples  were  missing  and  required
nterpolation.  Conﬁdence  interval  used  for  all  analyses  was
5%.  Effect  sizes  were  calculated  using  Cohen’s  d.
Descriptive  statistics  were  applied  on  the  items  of  ad  hoc
cales  about  A-CRA  and  CM.  The  most  representative  data
rom  the  qualitative  reports  was  selected  by  the  research
190  S.  Fernández-Artamendi  et  al.
Table  1  Baseline  characteristics  of  participants.
Participants  characteristics  A-CRA  (16)  A-CRA  +  CM  (8)  F  p
Sex  (%  male)  87.5%  100% * .536
Years of  age  [M(SD)]  16.31  (1.25)  16.88  (.99)  1.22  .280
Age of  onset  cannabis  use  14.38  (1.50)  14.38  (1.30)  0.00  1.000
Months cannabis  use  [M(SD)]  24.75  (15.08)  36.87  (12.86)  3.77  .065
Cannabis Abuse  Diagnosis  (%)  85.7%  87.5% * 1.000
Days cannabis  use  last  30  days  [M(SD)]  12.63  (11.68)  12.75  (12.27)  0.00  .981
Days alcohol  use  last  30  days  [M(SD)]  4.00  (4.16)  2.86  (2.73)  0.42  .524
History legal  issues  (%)  25.0%  37.5% * .647
Other illicit  drug  use  (%) 18.8% 0% * .526
CPQ-A [M(SD)] 7.81  (5.61) 9.13  (6.85) 0.25 .620
BDI-II [M(SD)] 8.56  (7.28) 11.71  (11.06) 0.66 .424
CBCL Global  Score  64.06  (8.46)  66.29  (7.20)  0.36  .552
No statistically signiﬁcant differences (p > .05) were found between groups in baseline characteristics (Table 1). Regarding gender, the
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tonly two girls in the study entered the A-CRA group.
* Fisher Exact Test
eam  and  was  used  to  support  the  discussion  of  the  results
rovided  by  quantitative  data.
esults
articipants
aseline  characteristics  of  participants  included  in  the
tudy  are  shown  in  Table  1.  Most  participants  were  male
91.7%),  and  mean  age  was  16.50  (SD  =  1.18).  Mean  age  at
rst  cannabis  use  was  14.38  (SD  =  1.41),  with  an  average
f  28.79  months  (SD  =  15.26)  using  this  drug.  Of  the  total
ample,  86.4%  met  the  criteria  for  cannabis  abuse  as
eﬁned  in  the  DSM-IV-TR,  with  an  average  of  2.18  symptoms
SD  =  1.22).  Participants  reported  an  average  of  12.67  days
SD  =  11.61)  of  cannabis  use  in  the  last  30  days,  and  3.60
ays  (SD  =  3.69)  of  alcohol  use.  Other  experimental  illegal
rug  use  was  reported  by  12.5%  of  the  sample.  Nearly
ne-third  (29.2%)  was  or  had  been  involved  in  legal  issues.
R
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Table  2  Retention  and  abstinence  outcomes  by  treatment  group
Variables  A-CRA  (16)  
Retention  month  1 100%  
Retention month  2  81.3%  
Retention month  3  81.3%  
Abstinence month  1  62.5%  
Abstinence month  2  62.5%  
Abstinence month  3  68.8%  
Maximum continuous  abstinence  (weeks)  7.28  
Percentage of  negative  UAs  provided  64.14%  
Percentage abstinent  during  last  30  days  (UA’s)  37.5%  
Treatment outcomes.
Psychopathology
Clinical changes in each group were assessed for all participants who
n for A-CRA = 13; n for A-CRA + CM = 7). Point-prevalence abstinence 
considering missing samples as positive (conservative approach). Altho
during treatment in both groups, the only signiﬁcant changes were o
CRA + CM) and depressive symptoms (p = .015 for A-CRA; p = .019 for A-
* Fisher Exact Testarticipants  presented  a  mean  score  of  8.25  (SD  =  5.94)  on
PQ-A  and  9.52  (SD  =  8.47)  on  BDI-II.  Average  global  CBCL
core  was  64.74  (SD  =  8).
mplementation
he  average  number  of  A-CRA  sessions  per  patient  was  10.92
SD  =  2.59),  with  a  range  of  4  to  16.  Adolescents  in  the  A-
RA  +  CM  group  received  an  average  of  155.81D  (SD  =  88.29)
n  vouchers  during  the  treatment  program,  ranging  from
4D  to  248.5D . The  overall  budget  of  the  CM  program  was
,246.5D  .  Although  external  donations  were  not  actively
ought,  20.98%  of  vouchers  were  funded  by  companies  con-
acted  that  wanted  to  donate.etention
fter  1  month,  100%  of  participants  continued  attending
reatment  in  both  groups.  Whereas  retention  decreased  to
.
A-CRA  +  CM(8)  F  Effect  Size  p
100% * --  --
100% * 0.89  .526
100% * 0.89  .526
87.5% * 0.60  .352
75.0% * 0.27  .667
75.5% * 0.15  1.000
6.94  0.02  0.07  .865
67.23%  0.04  0.07  .833
37.5% * 0.00  1.000
 completed assessments at intake and end of treatment (N = 20;
rates were calculated for all participants in the study (N = 24),
ugh all clinical scores decreased and abstinence rates increased
n cannabis-related problems (p = .007 for A-CRA; p = .039 for A-
CRA + CM)(see Table 3).
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81.3%  in  A-CRA  at  months  2  and  3,  it  remained  100%  in
the  A-CRA  +  CM  group.  No  signiﬁcant  differences  were  found
between  groups  (p>  .05)  (see  Table  2).
Abstinence
Rates  of  point-prevalence  abstinence  as  assessed  by  UAs  at
months  1,  2  and  3  were  higher  in  the  A-CRA  +  CM  group,  with
a  ﬁnal  rate  of  75.5%  at  the  end  of  treatment,  but  differ-
ences  were  non-signiﬁcant.  In  A-CRA,  abstinence  at  the  end
of  treatment  was  68.8%.  Maximum  continuous  abstinence
was  7.28  weeks  in  A-CRA  and  6.94  in  A-CRA  +  CM,  with  no
signiﬁcant  differences  between  groups.  Regarding  rates  of
adolescents  in-recovery,  in  both  groups  37.5%  of  adolescents
were  abstinent  and  in  the  community  in  the  last  30  days  of
treatment.  See  Table  2.
Feedback from therapists
Four  therapists  completed  questionnaires  on  A-CRA  and  A-
CRA  +  CM.  Therapists’  opinions  on  both  approaches  were
very  positive  (4.5  in  both  cases).  Clinicians  considered  CM
to  work  better  (4)  with  adolescents  than  A-CRA  (3.25),
and  were  more  likely  to  continue  using  CM  techniques  (5)
than  A-CRA  treatment  (3.75).  The  experience  of  imple-
menting  both  programs  was  positive  (A-CRA:  4.5;  CM:  3.5).
Regarding  detected  barriers,  clinicians  considered  their  sig-
niﬁcance  was  low:  Lack  of  institutional  support  (A-CRA:  1.5;
CM:  1),  lack  of  training  (1.25;  1),  lack  of  interest  from
patients  (2;  1.5)  and  lack  of  clinical  utility  (1.5;  1).  The
lack  of  time/high  caseload  was  highlighted  as  the  more  sig-
niﬁcant  barrier  (3.25;  2.5).  All  therapists  considered  very
important  (5)  to  continue  extending  implementation  of
EBTs  in  regular  practice  at  the  Spanish  Public  Health  Sys-
tem.
Discussion
This  is  the  ﬁrst  study  to  implement  an  EBT  for  adoles-
cent  CUD  in  Spain,  and  more  speciﬁcally  in  the  Public
Health  System.  Implementing  A-CRA  and  CM  in  this  con-
text  was  feasible  and  had  positive  results.  However,  the
clinical  effectiveness  of  A-CRA  and  CM  when  compared  to
other  interventions  utilized  in  these  contexts  still  needs
further  study.  The  addition  of  CM  to  A-CRA  as  a  way  of
improving  outcomes  by  reinforcing  abstinence  needs  more
research  too.  We  found  signiﬁcant  barriers  that  alerted  us
to  certain  obstacles  in  the  implementation  of  evidence-
based  programs  in  the  Public  Health  System,  giving  us  useful
information  on  how  to  proceed  with  future  implementation
efforts.
Implementation process
Several  factors  hindered  the  implementation  of  the  treat-
ment  program  and  limited  the  eventual  sample  size  of  the
study  to  26  participants.  During  the  24  month  course  of  this
project  only  133  eligible  adolescents  sought  treatment  in
the  participating  clinical  settings.  The  second  factor  that
limited  the  sample  size  was  the  establishment  of  inclusion
t
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nd  exclusion  criteria.  Eventually,  107  adolescents  were
neligible  for  the  study  based  on  exclusion  criteria,  mostly
he  presence  of  other  mental  health  issues  referred  to  more
peciﬁc  interventions  and  lack  of  family  support.  Given  the
nﬂuence  of  family  involvement  (Cerezo,  Méndez,  &  Alto,
013) and  comorbid  disorders  (López-Villalobos,  Andrés-de
lano,  Sánchez-Azón,  Sanguino-Andres,  &  Alberola-López,
012) on  disruptive  behaviors  such  as  substance  abuse,  these
xclusions  might  have  contributed  to  our  positive  results.
hese  adolescents  were  referred  to  more  specialized  ser-
ices.  Future  research  studies  could  include  these  and  other
linical  proﬁles  of  adolescent  cannabis  users  since  A-CRA  has
hown  to  be  effective  among  young  adults  (Smith,  Godley,
odley,  &  Dennis,  2011),  adolescent  using  other  drugs
Slesnick,  Prestopnik,  Meyers,  &  Glassman,  2007) and  pre-
enting  internalizing  and/or  externalizing  disorders  (Godley
t  al.,  2014).  Qualitative  reports  from  therapists  underscore
his  fact,  since  they  considered  A-CRA  and  A-CRA  +  CM  were
uitable  for  a  broader  population  of  adolescents.
Since  therapists’  participation  in  the  study  was  voluntary
nd  based  on  time  availability,  qualitative  reports  showed
hat  they  could  not  have  integrated  more  study  cases  in
heir  regular  caseloads;  although  only  .01%  of  cases  were
ventually  excluded  due  to  this  reason.  Previous  studies
ave  shown  that  organizational  issues  can  be  a  signiﬁcant
arrier  to  implement  EBTs  (Lundgren,  Chassler,  Amodeo,
’Ippolito,  &  Sullivan,  2012).  Lack  of  time  also  prevented
herapists  from  utilizing  some  outreach  techniques  inher-
nt  to  the  A-CRA  approach,  such  as  treatment  delivery
utside  the  clinical  setting  (Godley,  Meyers,  et  al.,  2001).
iven  the  greater  complexity  of  A-CRA  compared  to  CM,  this
ight  have  contributed  to  lower  scores  from  therapists  on
heir  evaluation.  In  future  experiences,  utilizing  other  for-
ats  for  A-CRA  could  help  delivering  treatment  to  broader
amples  in  these  public  contexts.  Previous  experiences
sing  group  format  with  A-CRA  in  the  US  (Godley,  Smith,
eyers,  &  Godley,  2009;  Slesnick  et  al.,  2007),  and  CRA  in
pain  (Garcia-Fernandez  et  al.,  2011)  have  obtained  posi-
ive  results.  Other  approaches  such  as  telehealth  procedures
ave  shown  to  be  effective  for  psychological  treatments
Pen˜ate,  2012).
Regarding  CM,  previous  studies  have  shown  practi-
ioners  as  scarcely  motivated  for  its  implementation  by
omparison  with  other  new  evidence-based  behavioral  tech-
iques  (McGovern,  Fox,  Xie,  &  Drake,  2004).  Actually,  CM
s  an  unfamiliar  approach  for  many  treatment  providers
McGovern  et  al.,  2004),  who  ﬁnd  it  too  expensive  (Kirby,
enishek,  Dugosh,  &  Kerwin,  2006).  Whereas  previous  fea-
ibility  studies  have  found  many  signiﬁcant  obstacles  to
he  implementation  of  CM  (Killeen,  McRae-Clark,  Waldrop,
padhyaya,  &  Brady,  2012),in  our  case,  there  were  no  signif-
cant  barriers.  According  to  therapists,  ‘‘it  helps  to  motivate
dolescents  by  offering  new  positive  reinforcers  in  line  with
herapeutic  goals’’.  The  main  reported  limitation  was  ‘‘the
ifﬁculties  to  include  such  programs  within  the  budget  of  the
nstitution’’.  In  this  regard,  this  study  did  not  actively  seek
ltruist  donations,  but  20.98%  of  vouchers  were  funded  by
ompanies  that  proposed  to  donate.  Some  protocols  exist
hat  contribute  to  building  a  voucher  program  with  up  to
8%  of  companies  providing  services  free  of  charge  or  with
ome  discount  (García-Rodriguez,  Secades-Villa,  Higgins,
ernández-Hermida,  &  Carballo,  2008).
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linical outcomes
o  evidence-based  treatments  or  systematic  UAs  were  being
egularly  delivered  by  the  collaborating  clinical  settings.
ack  of  experimental  control  on  extant  treatment  programs
mplemented  at  these  institutions  obliged  us  to  dismiss
reating  a  control  group,  which  thus  prevented  us  from
omparing  the  effectiveness  of  the  two  EBT  conditions  to
tandard  treatment  programs.  The  limited  sample  size  might
lso  have  prevented  us  from  obtaining  signiﬁcant  differences
n  effectiveness  between  both  approaches.  These  limita-
ions  notwithstanding,  this  experience  has  shed  some  light
n  the  clinical  outcomes  of  selected  EBTs  when  implemented
n  this  public  context.
When  evaluating  clinical  outcomes,  only  cannabis-
elated  problems  and  depressive  symptoms  showed  signif-
cant  decreases  after  treatment,  although  a  non-signiﬁcant
eduction  can  be  observed  in  other  clinical  variables.  The
ack  of  a  control  group  and  the  limited  sample  size  do
ot  allow  us  to  determine  whether  these  were  direct
ffects  of  A-CRA  or  CM.  Retention  rates  showed  that  A-CRA
nd  A-CRA  +  CM  generate  engagement,  with  no  signiﬁcant
mprovements  associated  to  the  utilization  of  CM.  Nev-
rtheless,  and  in  line  with  previous  studies  with  adults
Budney  &  Higgins,  1998;  Secades-Villa,  García-Rodríguez,
iggins,  Fernández-Hermida,  &  Carballo,  2008),  adding  CM
o  CRA  proved  feasible,  and  both  techniques  were  readily
ntegrated,  with  no  additional  difﬁculties.  Further  studies
hould  analyze  whether  this  rates  are  a  signiﬁcant  improve-
ent  when  compared  to  engagement  in  treatment  as  usual
t  these  resources.
Most  participants  achieved  high  rates  of  abstinence,  with
n  average  70.8%  point-prevalence  rate  at  the  end  of  treat-
ent  and  37.5%  of  adolescents  in-recovery,  according  to
A’s.  This  latter  rate  is  higher  than  the  self-reported  rate
f  24%  across  conditions  and  follow-ups  in  the  CYT  study
Dennis  et  al.,  2004).  In  our  study,  utilization  of  UA’s  might
e  contributing  to  improved  abstinence  outcomes  in  both
roups  (Sánchez-Hervás  et  al.,  2010).  A-CRA  resulted  a use-
ul  approach  to  reduce  cannabis  use  among  adolescents
n  our  study,  with  similar  rates  of  adolescents  in-recovery
cross  conditions.  The  same  is  shown  regarding  continu-
us  abstinence,  where  adolescents  achieved  an  average
f  7  weeks  in  both  groups,  without  signiﬁcant  differences
etween  them.  This  rate  is  similar  to  the  7.6  weeks  achieved
n  the  CM  group  in  the  study  of  Stanger  et  al.  (2009).  Due
o  the  lack  of  a  control  group  we  cannot  determine  whether
ur  results  are  fully  attributable  to  the  interventions  imple-
ented,  or  if  adding  CM  to  A-CRA  had  signiﬁcant  additive
ffects  on  this  approach.  Future  studies  with  larger  sam-
les  are  needed  to  establish  conclusions  on  differences  in
fﬁcacy  between  conditions.
imitations
ur  results  indicate  that  using  A-CRA  and  A-CRA  +  CM  in  the
ublic  System  is  feasible.  However,  several  methodological
ssues  limit  the  extent  of  our  ﬁndings.  First,  the  lack  of  a
ontrol  group  prevented  us  from  comparing  these  EBTs  with
reatment  as  usual  and  determining  whether  signiﬁcant
ecreases  in  clinical  symptomatology  are  due  to  the  inter-
t
o
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entions  implemented.  Low  utilization  of  treatment  services
nd  strict  inclusion/exclusion  criteria  restricted  the  sample
ize  to  26  participants,  limiting  the  power  of  our  statistical
nalyses  and  excluding  other  potential  beneﬁciaries.  Thera-
ists  had  to  deliver  EBTs  while  providing  treatment  as  usual
o  other  patients,  which  consumed  much  of  their  time  and
revented  them  from  deploying  all  the  outreach  techniques
uggested  in  the  A-CRA  manual,  which  could  have  improved
nrollment  and  retention.  No  monitoring  of  therapists  could
e  conducted  by  means  of  videotaping  or  recordings,  so
delity  to  the  model  relied  upon  intensive  training  (15  hours)
nd  continuous  clinical  assistance.  Utilizing  UA’s  in  the  A-
RA  group  was  necessary  to  monitor  abstinence  but  it  might
ave  had  an  effect  on  these  rates  given  the  natural  con-
equences  provided  by  the  family  based  on  its  results.  This
ould  have  concealed  between-group  differences,  minimiz-
ng  the  effects  of  the  vouchers  schedule  in  the  A-CRA  +  CM
roup.Only  one  follow-up  at  the  end  of  treatment  was  con-
ucted,  so  further  research  should  analyze  the  stability  of
reatment  effects  and  the  feasibility  of  multiple  follow-ups.
onclusions
his  is  the  ﬁrst  study  to  implement  EBTs  with  adolescent
annabis  users  in  Spain,  and  the  ﬁrst  reported  experience
f  such  interventions  in  the  Public  System.  Since  there  was
o  control  group  we  could  not  determine  the  clinical  efﬁ-
acy  of  A-CRA  and  CM  compared  to  other  regular  services.
hen  compared  to  previous  studies,  A-CRA  and  CM  resem-
le  positive  results  achieved  by  previous  studies  regarding
etention  or  abstinence,  and  their  utilization  in  this  con-
ext  was  feasible.  Treatment  outcomes  indicated  that  CM
id  not  have  a  signiﬁcant  effect  on  abstinence  or  reten-
ion  rates  of  A-CRA.  However,  this  needs  to  be  further
nalyzed  given  our  small  sample  size.  Despite  signiﬁcant
mprovements  in  cannabis-related  problems  and  depressive
ymptoms,  we  cannot  attribute  them  exclusively  to  the
nterventions  implemented  due  to  the  absence  of  a  com-
arison  group  (Table  3).
No  comparable  data  from  other  controlled  studies  or
nterventions  applied  in  this  context  has  been  found  that
llow  us  to  compare  the  efﬁcacy  of  the  programs  utilized
ere.  This  research  sheds  light  on  the  obstacles  that  need  to
e  overcome  to  conduct  such  studies  here  on  and  it  encour-
ges  further  exploration  of  A-CRA  and  CM,  as  well  as  other
lternative  EBTs,  within  the  Public  Health  System  to  deter-
ine  their  effectiveness.In  this  sense,  some  recommenda-
ions  for  improving  the  use  and  acceptability  of  these  EBTs  in
he  Public  System  are  suggested:  (1)  Extending  their  utiliza-
ion  to  broader  samples  of  adolescent  drug  users;  (2)  utiliz-
ng  a  group  format  that  could  make  A-CRA  more  feasible  for
verloaded  resources;  (3)  improving  recruitment  strategies
o  promote  adolescents’  utilization  of  outpatient  services
hen  experiencing  drug-use  problems;  (4)  utilizing  existing
rotocols  to  help  funding  CM  programs  through  donations
García-Rodriguez  et  al.,  2008),  facilitating  its  implementa-
ion  in  diverse  clinical  settings;  and  (5)  extending  the  use
f  CM  techniques  to  reinforce  clinical  evaluations  and  com-
letion  of  assessment  instruments,  which  would  increase
articipants’  compliance  with  the  evaluation  process.
Evidence-based  treatments  for  adolescents  with  cannabis  use  disorders  in  the  Spanish  Public  Health  System  193
Table  3  Clinical  outcomes  by  treatment  group.
Variables  Groups  Intake  End  of
treatment
Student  t  Effect  size  p
CBCL  Internalizing  A-CRA  64.23  (10.13)  61.38  (7.89)  1.82  .095
A-CRA +  CM  59.14  (11.48)  55.23  (13.55)  1.19  .280
CBCL Externalizing  A-CRA  64.69  (8.31)  62.46  (8.74)  1.05  .313
A-CRA +  CM  68.86  (4.14)  61.86  (12.67)  1.91  .105
CBCL Global  Score  A-CRA  64.15  (8.91)  61.69  (10.46)  1.31  .216
A-CRA +  CM  66.29  (7.20)  59.29  (13.71)  1.91  .104
CPQ-A A-CRA  7.46  (5.16)  3.46  (2.70)  3.24  0.97  .007
A-CRA +  CM 10.00  (6.90) 3.43  (4.39) 2.63 1.14  .039
BDI-II A-CRA  8.54  (7.89) 5.31  (8.32) 2.85 0.40  .015
A-CRA +  CM 13.17  (11.35) 6.17  (8.52) 3.39 0.70 .019
Rates of  Cannabis
point-prevalence
Abstinence
A-CRA  31.3%  68.8% * .  .484
A-CRA +  CM  25%  75%  .536
F
G
G
G
G
G
G
G
G* Fisher Exact Test.
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